The Market is Cooking with Oil

October 15, 2025

DENVER, Colo., Oct 15, 2025 (247marketnews.com)- Wall Street is moving on President Donald Trump’s latest post about China and cooking oil.

Markets were jolted late yesterday after Trump declared “we can easily produce Cooking Oil ourselves,” rather than depend on “corrupt trade deals” with China, sparking a speculative rally in U.S.-based and China-exposed agricultural players. Trump’s protectionist statement is fanning fears of renewed trade friction, while also igniting hope among domestic producers and biotech innovators.

The two biggest winners appear to be:

  • Australian Oilseeds Holdings (NASDAQ:COOT) soared, as the sustainable edible oil producer is seen as a potential major beneficiary of redirected domestic oil demand. Investors are betting on a boom in alternative sourcing as the U.S. re-evaluates ag imports from China.
  • Sadot Group (NASDAQ:SDOT) also leapt higher. The global agribusiness operator, with supply chain integration from farm to fork, is gaining attention as a scalable play in global food resilience.

VENU (NYSE:VENU), the entertainment infrastructure upstart reimagining amphitheater design, is rallying after releasing renderings for its multi-season Sunset Amphitheaters in McKinney, Texas, and Broken Arrow, Oklahoma.

Key catalysts:

  • $23 million in Luxe FireSuite demand in just the last 60 days.
  • A $34 million capital raise led by ThinkEquity at ~$12/share.
  • Cultural backing from Dierks Bentley, Billboard, and Terri Liebler’s addition to the Rolling Stone Culture Council.

With amphitheaters now boasting wind wall technology, heated canopies, and year-round programming, VENU is positioning itself not just as a music venue builder, but a premium lifestyle brand, and Wall Street is starting to hum along.

Novo Nordisk A/S has announced a definitive asset purchase and license agreement with Omeros Corporation (NASDAQ:OMER) for zaltenibart (formerly OMS906), a clinical-stage MASP-3 inhibitor targeting rare blood and kidney disorders. Under the deal, Novo Nordisk gains exclusive global rights to develop and commercialize zaltenibart, with Omeros receiving $340 million in upfront and near-term milestone payments, and potential total payments reaching $2.1 billion, including development and commercial milestones, plus tiered royalties on future sales.

Zaltenibart works by inhibiting MASP-3, a key activator in the alternative complement pathway, which is implicated in diseases such as paroxysmal nocturnal hemoglobinuria (PNH). The candidate has shown promising phase 2 results, demonstrating strong efficacy, favorable tolerability, and potential advantages over existing and in-development treatments. Novo Nordisk plans to launch a global phase 3 program in PNH, with additional indications in rare blood and kidney conditions under evaluation. Executives from both companies emphasized the drug’s best-in-class potential and the opportunity to address high unmet needs in complement-mediated diseases.

While Novo Nordisk will assume full control of zaltenibart’s development, Omeros retains rights to its preclinical MASP-3 programs, including small-molecule inhibitors for limited indications. The deal is expected to close in Q4 2025, pending regulatory approvals. Omeros will now shift focus toward the approval and commercialization of narsoplimab, its lead candidate, while Novo Nordisk strengthens its position as a global leader in the rare disease space.

While the world obsesses over chips and compute, Veritone (NASDAQ:VERI) is betting big on the third pillar of AI: training data.

The company announced:

  • Major contract wins with leading hyperscalers for its Veritone Data Refinery (VDR), pushing bookings to nearly $40 million.
  • Preliminary Q3 revenue between $28.5M–$28.7M, up 30.5% YoY.

CEO Ryan Steelberg emphasized that unstructured data is “the most strategic and scarce resource in the AI economy.” As hyperscalers pay premiums for proprietary datasets, Veritone is emerging as a key gatekeeper in the AI data arms race.

In a surprising sector mashup, Innovation Beverage Group (NASDAQ:IBG) announced a reverse merger with BlockFuel Energy, a power-gen and Bitcoin mining company. The combined entity, trading under “FUEL” post-close, will blend:

  • IBG’s fast-growing beverage portfolio with
  • BlockFuel’s vertically integrated oil, gas, and power business targeting digital infrastructure.

Post-deal valuation could range between $220M and $343M, with IBG shareholders retaining 10% ownership in the merged company.

CEO Daniel Lanskey says the deal creates a powerful foundation for long-term value.

Please click here to read Cenorium’s full Venu analyst report on 247marketnews.com.

For the full 24/7 Market News VENU report and in-depth insights, including analyst reports, visit: Read 24/7 Market News VENU Report/

Contact sales@247marketnews.com for Analyst Report coverage and other investor/public relations services.

24/7 MARKET NEWS, INC (247) Disclaimer and Disclosure
PAID EDITORIAL DISCLOSURE: 247MarketNews.com has been compensated $2,500 per week by MicroCap Strategies for ongoing press and editorial coverage of VENU. This is a paid editorial communication intended for informational purposes only. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/. This press release may include technical analysis for informational purposes only and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please go to https://247marketnews.com/venu-disclosure/ for additional 247marketnews.com VENU disclosure information.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (VENU, COOT, SDOT, OMER, VERI, IBG)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.